Breaking News
0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

Pfizer submits data for COVID-19 vaccine use in younger kids

Stock MarketsSep 28, 2021 04:45PM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
© Reuters. FILE PHOTO: A woman holds a small bottle labeled with a "Coronavirus COVID-19 Vaccine" sticker and a medical syringe in front of displayed Pfizer logo in this illustration taken, October 30, 2020. REUTERS/Dado Ruvic

(Reuters) - Pfizer Inc (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) on Tuesday submitted initial trial data for their COVID-19 vaccine in 5-11 year olds and said they would make a formal request to U.S. regulators for emergency use in the coming weeks.

The U.S. Food and Drug Administration said earlier this month it would look to complete its data review for this age group as quickly as possible, likely in a matter of weeks rather than months. That could mean an authorization of the shot for children by the end of October, sources have told Reuters.

The companies, however, have yet to start the official process for authorization, which could slow the decision. According to the Wall Street Journal, the FDA may not make its decision until sometime between Halloween and Thanksgiving, citing a person familiar with the matter.

A Pfizer spokesperson said the company expects to start and complete its application very soon.

A decision on the vaccine's use in younger children is eagerly awaited by millions of Americans as coronavirus infections have soared in children to the highest point in early September, according to data from the American Academy of Pediatrics.

The vaccine, which is already authorized for 12 to 15-year- olds and fully approved for ages 16 and up, induced a strong immune response in the target age group in a 2,268-participant clinical trial, the companies said on Sept. 20.

The Pfizer-BioNTech vaccine was authorized for the 12-15 age group roughly a month after the companies filed for authorization. If the same timeline is followed for this application, younger children could start receiving their shots as soon as late October.

A rapid authorization could help mitigate a potential surge of cases this fall, with schools already open nationwide.

While kids are less susceptible to severe COVID-19, they can spread the virus to others, including vulnerable populations that are more at risk of severe illness.

The companies said they plan to submit the data to the European Medicines Agency and other regulatory authorities. They also plan to submit data from the full late-stage trial for scientific peer-reviewed publication.

The FDA was not immediately available to comment.

Data from the companies' trial showed the two-shot vaccine generated an immune response in children that matched what was previously observed in 16-to-25 year olds. The safety profile was also comparable to the older age group, Pfizer said.

The drugmakers are also testing the vaccine in children aged 2-to-5 and those aged 6 months-to-2 years, with data expected in the fourth quarter.

Moderna (NASDAQ:MRNA)'s COVID-19 vaccine is not yet authorized for use in adolescents in the United States, while it has gained authorization for that age group in Europe.

Both the Pfizer and Moderna vaccines have been linked by regulators to rare cases of heart inflammation in adolescents and young adults, particularly young men. Pfizer said no instances of heart inflammation were seen in the trial participants.

Pfizer submits data for COVID-19 vaccine use in younger kids
 

Related Articles

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Comments (5)
ben sc
ben sc Sep 28, 2021 5:51PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
0% risk, anyone who jabs their kids should be reported to child protective services.
JohnCougar Femacamp
JohnCougar Femacamp Sep 28, 2021 9:32AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
these satanic vampires and the fradulent, unelected regime that enables them must be resisted at every single turn. the new world order is here, take a stand now for your children or perish as a slave to the nwo beast system. dont end up like australia. do NOT comply. instead, become ungovernable.
Necleus Electron
Necleus Electron Sep 28, 2021 8:33AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Seriously! Can you these money sucking pharma leave our kids alone!
James Canter
James Canter Sep 28, 2021 8:07AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Where is the immunity data for the ones who had. it?
Marc Hainey
Marc Hainey Sep 28, 2021 7:46AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Where is the medium - long term data before mass jabbing our children??
Paulo Roberto Carvalho
Paulo Roberto Carvalho Sep 28, 2021 7:46AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
should we wait for more contagions?
Josh Davis
Josh Davis Sep 28, 2021 7:46AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Paulo Roberto Carvalho there is always contagions bro. Its a virus no matter how many vaccines they will continue to decline in efficacy. Just like flu and all the other ones. I bet you think measles was abolished by vaccines too dont you? The answer is no it was 99.6% gone in the general public before the first vaccine jabbed.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email